Nomura Holdings Inc Stoke Therapeutics, Inc. Transaction History
Nomura Holdings Inc
- $46 Billion
- Q2 2025
A detailed history of Nomura Holdings Inc transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 20,400 shares of STOK stock, worth $546,924. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,400Holding current value
$546,924% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding STOK
# of Institutions
139Shares Held
57.6MCall Options Held
2.7KPut Options Held
57.4K-
Black Rock Inc. New York, NY5.41MShares$145 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.4MShares$145 Million18.16% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$137 Million0.89% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$124 Million0.53% of portfolio
-
Redmile Group, LLC San Francisco, CA4.38MShares$117 Million6.04% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $1.06B
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...